Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8625
Corporate User License Price USD 375
Corporate User License Price INR 25875
Site License Price USD 250
Site License Price INR 17250
Request a Quote

Report Title

Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review



Executive Summary

Biocon Ltd (BIOCON)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biocon Ltd (Biocon) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions like cancer, diabetes and autoimmune. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and complex biologics both novels and biosimilars including monoclonal antibodies (MAbs), rh-Insulin and insulin analogs. It also provides research services including discovery, development and manufacturing services for both small and large molecules. Biocon provides research solutions to the biotechnology and pharmaceutical companies worldwide. It has an overseas manufacturing facility at BioXcell, a biotechnology park in Johor, Malaysia. Biocon is headquartered in Bangalore, Karnataka, India.

Biocon Ltd Key Recent Developments

Jul 26,2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr

Jul 04,2018: Biocon's Sterile Drug Product facility Receives EU GMP Certification

Jun 23,2018: Biocon's Sterile Drug Product facility Receives EIR from U.S. FDA

May 02,2018: Biocon Regulatory Audit Update

Apr 26,2018: Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma-Biocon Ltd]

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Biocon Ltd-Key Facts 6

Biocon Ltd-Key Employees 7

Biocon Ltd-Key Employee Biographies 8

Biocon Ltd-Major Products and Services 9

Biocon Ltd-History 12

Biocon Ltd-Company Statement 17

Biocon Ltd-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 20

Section 2-Company Analysis 22

Company Overview 22

Biocon Ltd-Business Description 23

Business Segment: Biologics 23

Overview 23

Performance 23

Business Segment: Branded Formulations 23

Overview 23

Performance 23

Business Segment: Research Services 24

Overview 24

Performance 24

Business Segment: Small Molecules 24

Overview 24

Performance 24

Geographical Segment: India 24

Performance 24

Geographical Segment: Rest of the World 24

Performance 24

Geographical Segment: United States of America 24

Performance 24

R&D Overview 25

Biocon Ltd-Corporate Strategy 26

Biocon Ltd-SWOT Analysis 27

SWOT Analysis-Overview 27

Biocon Ltd-Strengths 27

Biocon Ltd-Weaknesses 28

Biocon Ltd-Opportunities 29

Biocon Ltd-Threats 30

Biocon Ltd-Key Competitors 31

Section 3-Company Financial Ratios 32

Financial Ratios-Capital Market Ratios 32

Financial Ratios-Annual Ratios 33

Performance Chart 36

Financial Performance 36

Financial Ratios-Interim Ratios 37

Financial Ratios-Ratio Charts 38

Section 4-Company's Lifesciences Financial Deals and Alliances 39

Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39

Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40

Biocon Ltd, Recent Deals Summary 41

Section 5-Company's Recent Developments 42

Jul 26, 2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr 42

Jul 04, 2018: Biocon's Sterile Drug Product facility Receives EU GMP Certification 45

Jun 23, 2018: Biocon's Sterile Drug Product facility Receives EIR from U.S. FDA 46

May 02, 2018: Biocon Regulatory Audit Update 47

Apr 26, 2018: Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma-Biocon Ltd] 48

Mar 13, 2018: Update On Company Statement On US-FDA Inspection At Biocon Malaysia 51

Dec 13, 2017: Biocon's Clarification post media reports on Biocon on the FDA list for not paying facility fee 52

Nov 20, 2017: Biocon's Drug product Facility Receives EIR with VAI status, Inspection Closed 53

Oct 26, 2017: Biocon Q2FY18 Revenues at Rs 1019 Crore; EBITDA at Rs 233 Crore; Net Profit at Rs 69 Crore 54

Oct 25, 2017: Biocon Ranked Among Top 10 Global Pharma & Biotech Employers 57

Section 6-Appendix 58

Methodology 58

Ratio Definitions 58

About GlobalData 62

Contact Us 62

Disclaimer 62

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Biocon Ltd, Performance Chart (2014-2018) 36

Biocon Ltd, Ratio Charts 38

Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39

Biocon Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 40

List of Tables

Biocon Ltd, Key Facts 6

Biocon Ltd, Key Employees 7

Biocon Ltd, Key Employee Biographies 8

Biocon Ltd, Major Products and Services 9

Biocon Ltd, History 12

Biocon Ltd, Subsidiaries 20

Biocon Ltd, Joint Venture 20

Biocon Ltd, Key Competitors 31

Biocon Ltd, Ratios based on current share price 32

Biocon Ltd, Annual Ratios 33

Biocon Ltd, Annual Ratios (Cont...1) 34

Biocon Ltd, Annual Ratios (Cont...2) 35

Biocon Ltd, Interim Ratios 37

Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39

Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40

Biocon Ltd, Recent Deals Summary 41

Currency Codes 58

Capital Market Ratios 58

Equity Ratios 59

Profitability Ratios 59

Cost Ratios 60

Liquidity Ratios 60

Leverage Ratios 61

Efficiency Ratios 61

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sun Pharmaceutical Industries Ltd

Serum Institute of India Ltd

Piramal Enterprises Ltd

Panacea Biotec Ltd

Morepen Laboratories Ltd

Dr. Reddy's Laboratories Ltd

Bharat Immunologicals and Biologicals Corp Ltd

Abeona Therapeutics Inc

Biocon Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person